Equities

Biolidics Ltd

Biolidics Ltd

Actions
Health CareMedical Equipment and Services
  • Price (SGD)0.011
  • Today's Change0.00 / 0.00%
  • Shares traded300.00
  • 1 Year change-21.43%
  • Beta0.4936
Data delayed at least 10 minutes, as of Jun 10 2024 01:58 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: Cancer, Infectious diseases, and Laboratory services. Its Cancer and infectious diseases segments involve the identifying and assessing potential collaboration partners, technology, products and services, product development, innovation and improvement and the management of global distributorship network and direct customers in the cancer field, and the infectious diseases field. The laboratory services segment involves the business, operation, and provision of laboratory services to customers. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing for COVID-19 in Singapore.

  • Revenue in SGD (TTM)272.00k
  • Net income in SGD-2.91m
  • Incorporated2009
  • Employees15.00
  • Location
    Biolidics Ltd37 Jalan Pemimpin, #02-07 MapexSINGAPORE 577177SingaporeSGP
  • Phone+65 64820668
  • Fax+65 64820778
  • Websitehttps://www.biolidics.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Robot SA6.56m-80.13k5.66m----0.72698.600.8634-0.0194-0.01941.601.870.39282.381.42---0.48-0.3968-0.7021-0.49810.4113.11-1.22-1.111.050.02090.5326--16.874.16-152.12---21.86--
Dorsavi Ltd1.31m-1.38m6.37m34.00--5.11--4.87-0.0029-0.00290.00270.00240.62470.42281.87---65.84-60.69-97.79-88.7184.5888.19-105.38-165.451.83-62.210.1012---25.62-14.77-18.52---52.15--
Thermogenesis Holdings Inc12.99m-19.93m6.45m25.00--4.89--0.4965-4.99-4.993.140.12260.64423.259.13384,400.00-105.49-78.08-221.76-133.9421.1029.01-163.77-133.660.3739-0.80281.35---9.90-0.4739-59.49--6.96--
Luxxu Group Ltd5.91m-7.38m6.53m56.00--0.4254--1.10-0.0791-0.07910.06340.16450.23560.59830.8658610,318.90-29.42-33.26-33.95-35.127.795.23-124.85-126.114.40-4.040.2545---50.83-21.6118.06------
Reflect Scientific Inc1.71m-463.88k6.70m7.00--2.67--3.91-0.004-0.0040.01480.02170.51290.61845.72181,111.40-13.8811.10-16.4313.2156.0662.48-27.0710.002.21--0.00---47.09-6.99-613.46------
Insplorion AB364.31k-2.91m7.02m12.00--2.11--19.26-2.52-2.520.18711.090.0797-2.105.58218,538.50-63.67-29.27-74.89-34.48238.58260.36-799.37-791.031.63--0.0409---2.70-4.88-14.18--12.48--
HitiQ Ltd842.88k-4.43m7.20m----39.02--8.54-0.0197-0.01970.00390.00060.2127--5.71---111.86---256.43-------525.82-----63.710.0991--26.43--27.49------
Hanvey Group Holdings Ltd32.13m-3.42m7.28m110.00--2.25--0.2266-0.1196-0.11961.120.11320.82845.049.311,687,882.00-8.89-6.91-23.71-19.1423.3324.18-10.74-7.460.9283-1.070.8947---31.880.3471-85.65---39.81--
Mantex AB875.89k-2.14m7.29m6.00--2.03--8.32-0.0813-0.08130.03320.11180.21680.248742.991,138,403.00-52.99-63.52-59.16-74.9179.0663.55-244.40-303.494.68-72.410.1288--373.294.58-7.49------
Biolidics Ltd272.00k-2.91m8.19m15.00------30.12-0.0045-0.00450.0004-0.00230.0991.191.1118,133.33-105.67-51.21---69.1957.7241.13-1,068.02-165.860.239-31.02-----47.170.73273.46------
Telesis Bio Inc33.30m-63.70m8.52m137.00------0.256-28.31-28.3114.8012.940.32313.275.58179,802.90-59.34---67.10--60.43---183.66--3.08-35.890.2015--0.2697---1.14------
Polarean Imaging PLC459.09k-19.29m8.93m28.00--0.3229--19.46-0.0449-0.04490.00110.03870.01530.11340.19719,534.09-64.22-59.80-72.25-68.3839.6559.23-4,201.18-574.074.66--0.0225---12.86-3.540.7877--30.60--
Memphasys Ltd41.91k-4.02m9.74m24.00--1.37--232.31-0.0046-0.00460.000050.00590.00330.2732-----31.43-16.26-46.11-19.7344.48---9,600.13-21,518.040.1368-11.780.456---43.39---63.43--8.14--
Aurora Solar Technologies Inc10.49m-1.69m10.91m----1.88--1.04-0.0098-0.00980.05050.02660.91081.517.98---14.71-82.57-22.77-106.4452.4143.93-16.15-135.081.22-39.660.0665----17.05-5.49--13.30--
Data as of Jun 10 2024. Currency figures normalised to Biolidics Ltd's reporting currency: Singapore Dollar SGD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.